Nadine S. Kaelber

Targeting prostate cancer cell lines with polo‐like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors

Michel D. Wissing, Janet Mendonca, Madeleine S.Q. Kortenhorst et al. · The FASEB Journal · 2013 · 34 citations · Full text

Medicine, Oncology, Pharmacology +15

Small-molecule screening of PC3 prostate cancer cells identifies tilorone dihydrochloride to selectively inhibit cell growth based on cyclin-dependent kinase 5 expression

Michel D. Wissing, Tikva Dadon, Eunice Kim et al. · Oncology Reports · 2014 · 26 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells

Michel D. Wissing, Janet Mendonca, Eunice Kim et al. · Cancer Biology & Therapy · 2013 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17